{"id":17809,"date":"2024-10-04T11:41:35","date_gmt":"2024-10-04T11:41:35","guid":{"rendered":"https:\/\/genekor.com\/2024\/10\/04\/fra-new-assay-pathology-lab\/"},"modified":"2024-10-04T11:41:35","modified_gmt":"2024-10-04T11:41:35","slug":"fra-new-assay-pathology-lab","status":"publish","type":"post","link":"https:\/\/genekor.com\/sk\/2024\/10\/04\/fra-new-assay-pathology-lab\/","title":{"rendered":"FR\u03b1: New Test at Genekor\u2019s Pathology Laboratory for Targeted Therapy of Ovarian Cancer"},"content":{"rendered":"\n<p>The FR\u03b1 test is performed for the administration of <strong>mirvetuximab soravtansine<\/strong> and is aimed at patients with<strong> platinum-resistant ovarian cancer <\/strong>who are <strong>FR\u03b1-positive <\/strong>and have received <strong>1-3 lines of therapy.<\/strong><\/p>\n\n\n\n<p>On September 19, 2024, the EMA issued a positive opinion for the administration of mirvetuximab soravtansine to patients with FR\u03b1-positive, platinum-resistant ovarian cancer who have received 1-3 lines of therapy, based on the phase <a href=\"https:\/\/mcusercontent.com\/84034efa59a7e43f306956007\/files\/3d31bf02-1f82-235c-a713-37695e89811a\/Mirasol_study_NEJM.pdf\">III MIRASOL study<\/a>.<br>In the <strong>US mirvetuximab soravtansine<\/strong> is FDA approved since March 2024.<\/p>\n\n\n\n<p><strong>Our pathology lab in Thessaloniki now performs the test for this specific biomarker (FRa).<\/strong><\/p>\n\n\n\n<p>Determination of FOLR1 (FR\u03b1) expression is performed in our laboratory using the <strong>FDA-approved Ventana\u00ae FOLR1 (FOLR1-2.1) RxDx Assay <\/strong>(Ventana Medical Systems, Inc.).<\/p>\n\n\n\n<p>In clinical practice, the sample is considered FOLR1 (FR\u03b1) positive if the neoplastic cells show moderate (2+) to intense (3+) complete or incomplete membrane staining in 75% or more of the sample. <\/p>\n\n\n\n<p>The sample is acceptable if it contains at least one hundred viable cancer cells. A positive external control is used.<\/p>\n\n\n\n<p><a href=\"https:\/\/mcusercontent.com\/84034efa59a7e43f306956007\/files\/b97bc8da-6251-82ad-4bc5-500078d28bd9\/EMA_CHMP_summary_positive_opinion_mirvetuximab_soravtansine_en.pdf\">See the EMA Positive Opinion<\/a><\/p>\n\n\n\n<p>The experienced and specialized staff of Genekor is here to provide physicians with the most reliable and accurate results, in order to enhance their efforts to offer the best possible care to their patients.<\/p>\n\n\n\n<p><a href=\"https:\/\/genekor.com\/wp-content\/uploads\/2024\/10\/\u03b5\u03be\u03b5\u03c4\u03b1\u03c3\u03b5\u03b9\u03c2-\u03c0\u03b1\u03b8\u03bf\u03bb\u03bf\u03b7\u03b3\u03bf\u03b1\u03bd\u03b1\u03c4\u03bf\u03bc\u03b9\u03ba\u03bf-genekor.pdf\">See the tests conducted at Genekor\u2019s pathology lab.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The FR\u03b1 test is performed for the administration of mirvetuximab soravtansine and is aimed at patients with platinum-resistant ovarian cancer who are FR\u03b1-positive and have received 1-3 lines of therapy. [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":17810,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[144,130],"tags":[],"class_list":["post-17809","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-sk","category-uncategorized-sk"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.0) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>FR\u03b1: New Test at Genekor\u2019s Pathology Laboratory for Targeted Therapy of Ovarian Cancer - Genekor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/genekor.com\/sk\/2024\/10\/04\/fra-new-assay-pathology-lab\/\" \/>\n<meta property=\"og:locale\" content=\"sk_SK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FR\u03b1: New Test at Genekor\u2019s Pathology Laboratory for Targeted Therapy of Ovarian Cancer\" \/>\n<meta property=\"og:description\" content=\"The FR\u03b1 test is performed for the administration of mirvetuximab soravtansine and is aimed at patients with platinum-resistant ovarian cancer who are FR\u03b1-positive and have received 1-3 lines of therapy. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/genekor.com\/sk\/2024\/10\/04\/fra-new-assay-pathology-lab\/\" \/>\n<meta property=\"og:site_name\" content=\"Genekor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/genekorbiotechnology\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-04T11:41:35+00:00\" \/>\n<meta name=\"author\" content=\"Ioanna Potska\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Autor\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ioanna Potska\" \/>\n\t<meta name=\"twitter:label2\" content=\"Predpokladan\u00fd \u010das \u010d\u00edtania\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 min\u00fata\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/genekor.com\\\/sk\\\/2024\\\/10\\\/04\\\/fra-new-assay-pathology-lab\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/genekor.com\\\/sk\\\/2024\\\/10\\\/04\\\/fra-new-assay-pathology-lab\\\/\"},\"author\":{\"name\":\"Ioanna Potska\",\"@id\":\"https:\\\/\\\/genekor.com\\\/sk\\\/#\\\/schema\\\/person\\\/d6c43cd4b4be66582d408967392cbcbd\"},\"headline\":\"FR\u03b1: New Test at Genekor\u2019s Pathology Laboratory for Targeted Therapy of Ovarian Cancer\",\"datePublished\":\"2024-10-04T11:41:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/genekor.com\\\/sk\\\/2024\\\/10\\\/04\\\/fra-new-assay-pathology-lab\\\/\"},\"wordCount\":225,\"publisher\":{\"@id\":\"https:\\\/\\\/genekor.com\\\/sk\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/genekor.com\\\/sk\\\/2024\\\/10\\\/04\\\/fra-new-assay-pathology-lab\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/genekor.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/FRa.png\",\"articleSection\":[\"news\",\"Uncategorized @sk\"],\"inLanguage\":\"sk-SK\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/genekor.com\\\/sk\\\/2024\\\/10\\\/04\\\/fra-new-assay-pathology-lab\\\/\",\"url\":\"https:\\\/\\\/genekor.com\\\/sk\\\/2024\\\/10\\\/04\\\/fra-new-assay-pathology-lab\\\/\",\"name\":\"FR\u03b1: New Test at Genekor\u2019s Pathology Laboratory for Targeted Therapy of Ovarian Cancer - Genekor\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/genekor.com\\\/sk\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/genekor.com\\\/sk\\\/2024\\\/10\\\/04\\\/fra-new-assay-pathology-lab\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/genekor.com\\\/sk\\\/2024\\\/10\\\/04\\\/fra-new-assay-pathology-lab\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/genekor.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/FRa.png\",\"datePublished\":\"2024-10-04T11:41:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/genekor.com\\\/sk\\\/2024\\\/10\\\/04\\\/fra-new-assay-pathology-lab\\\/#breadcrumb\"},\"inLanguage\":\"sk-SK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/genekor.com\\\/sk\\\/2024\\\/10\\\/04\\\/fra-new-assay-pathology-lab\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sk-SK\",\"@id\":\"https:\\\/\\\/genekor.com\\\/sk\\\/2024\\\/10\\\/04\\\/fra-new-assay-pathology-lab\\\/#primaryimage\",\"url\":\"https:\\\/\\\/genekor.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/FRa.png\",\"contentUrl\":\"https:\\\/\\\/genekor.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/FRa.png\",\"width\":2828,\"height\":1895},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/genekor.com\\\/sk\\\/2024\\\/10\\\/04\\\/fra-new-assay-pathology-lab\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/genekor.com\\\/sk\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FR\u03b1: New Test at Genekor\u2019s Pathology Laboratory for Targeted Therapy of Ovarian Cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/genekor.com\\\/sk\\\/#website\",\"url\":\"https:\\\/\\\/genekor.com\\\/sk\\\/\",\"name\":\"Genekor\",\"description\":\"\u039c\u03bf\u03c1\u03b9\u03b1\u03ba\u03ae \u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03ae\",\"publisher\":{\"@id\":\"https:\\\/\\\/genekor.com\\\/sk\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/genekor.com\\\/sk\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sk-SK\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/genekor.com\\\/sk\\\/#organization\",\"name\":\"Genekor\",\"url\":\"https:\\\/\\\/genekor.com\\\/sk\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sk-SK\",\"@id\":\"https:\\\/\\\/genekor.com\\\/sk\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/genekor.com\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/logo-black.svg\",\"contentUrl\":\"https:\\\/\\\/genekor.com\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/logo-black.svg\",\"width\":1,\"height\":1,\"caption\":\"Genekor\"},\"image\":{\"@id\":\"https:\\\/\\\/genekor.com\\\/sk\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/genekorbiotechnology\\\/\",\"https:\\\/\\\/gr.linkedin.com\\\/company\\\/genekor-sa\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCKC7sMFecVBY-OZAlRBHNzA\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/genekor.com\\\/sk\\\/#\\\/schema\\\/person\\\/d6c43cd4b4be66582d408967392cbcbd\",\"name\":\"Ioanna Potska\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sk-SK\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/51a22c866b60a1ab865aba05d68e60b9ed650b786b5ca87a11bb122b20cf2789?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/51a22c866b60a1ab865aba05d68e60b9ed650b786b5ca87a11bb122b20cf2789?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/51a22c866b60a1ab865aba05d68e60b9ed650b786b5ca87a11bb122b20cf2789?s=96&d=mm&r=g\",\"caption\":\"Ioanna Potska\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"FR\u03b1: New Test at Genekor\u2019s Pathology Laboratory for Targeted Therapy of Ovarian Cancer - Genekor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/genekor.com\/sk\/2024\/10\/04\/fra-new-assay-pathology-lab\/","og_locale":"sk_SK","og_type":"article","og_title":"FR\u03b1: New Test at Genekor\u2019s Pathology Laboratory for Targeted Therapy of Ovarian Cancer","og_description":"The FR\u03b1 test is performed for the administration of mirvetuximab soravtansine and is aimed at patients with platinum-resistant ovarian cancer who are FR\u03b1-positive and have received 1-3 lines of therapy. [&hellip;]","og_url":"https:\/\/genekor.com\/sk\/2024\/10\/04\/fra-new-assay-pathology-lab\/","og_site_name":"Genekor","article_publisher":"https:\/\/www.facebook.com\/genekorbiotechnology\/","article_published_time":"2024-10-04T11:41:35+00:00","author":"Ioanna Potska","twitter_card":"summary_large_image","twitter_misc":{"Autor":"Ioanna Potska","Predpokladan\u00fd \u010das \u010d\u00edtania":"1 min\u00fata"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/genekor.com\/sk\/2024\/10\/04\/fra-new-assay-pathology-lab\/#article","isPartOf":{"@id":"https:\/\/genekor.com\/sk\/2024\/10\/04\/fra-new-assay-pathology-lab\/"},"author":{"name":"Ioanna Potska","@id":"https:\/\/genekor.com\/sk\/#\/schema\/person\/d6c43cd4b4be66582d408967392cbcbd"},"headline":"FR\u03b1: New Test at Genekor\u2019s Pathology Laboratory for Targeted Therapy of Ovarian Cancer","datePublished":"2024-10-04T11:41:35+00:00","mainEntityOfPage":{"@id":"https:\/\/genekor.com\/sk\/2024\/10\/04\/fra-new-assay-pathology-lab\/"},"wordCount":225,"publisher":{"@id":"https:\/\/genekor.com\/sk\/#organization"},"image":{"@id":"https:\/\/genekor.com\/sk\/2024\/10\/04\/fra-new-assay-pathology-lab\/#primaryimage"},"thumbnailUrl":"https:\/\/genekor.com\/wp-content\/uploads\/2024\/10\/FRa.png","articleSection":["news","Uncategorized @sk"],"inLanguage":"sk-SK"},{"@type":"WebPage","@id":"https:\/\/genekor.com\/sk\/2024\/10\/04\/fra-new-assay-pathology-lab\/","url":"https:\/\/genekor.com\/sk\/2024\/10\/04\/fra-new-assay-pathology-lab\/","name":"FR\u03b1: New Test at Genekor\u2019s Pathology Laboratory for Targeted Therapy of Ovarian Cancer - Genekor","isPartOf":{"@id":"https:\/\/genekor.com\/sk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/genekor.com\/sk\/2024\/10\/04\/fra-new-assay-pathology-lab\/#primaryimage"},"image":{"@id":"https:\/\/genekor.com\/sk\/2024\/10\/04\/fra-new-assay-pathology-lab\/#primaryimage"},"thumbnailUrl":"https:\/\/genekor.com\/wp-content\/uploads\/2024\/10\/FRa.png","datePublished":"2024-10-04T11:41:35+00:00","breadcrumb":{"@id":"https:\/\/genekor.com\/sk\/2024\/10\/04\/fra-new-assay-pathology-lab\/#breadcrumb"},"inLanguage":"sk-SK","potentialAction":[{"@type":"ReadAction","target":["https:\/\/genekor.com\/sk\/2024\/10\/04\/fra-new-assay-pathology-lab\/"]}]},{"@type":"ImageObject","inLanguage":"sk-SK","@id":"https:\/\/genekor.com\/sk\/2024\/10\/04\/fra-new-assay-pathology-lab\/#primaryimage","url":"https:\/\/genekor.com\/wp-content\/uploads\/2024\/10\/FRa.png","contentUrl":"https:\/\/genekor.com\/wp-content\/uploads\/2024\/10\/FRa.png","width":2828,"height":1895},{"@type":"BreadcrumbList","@id":"https:\/\/genekor.com\/sk\/2024\/10\/04\/fra-new-assay-pathology-lab\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/genekor.com\/sk\/"},{"@type":"ListItem","position":2,"name":"FR\u03b1: New Test at Genekor\u2019s Pathology Laboratory for Targeted Therapy of Ovarian Cancer"}]},{"@type":"WebSite","@id":"https:\/\/genekor.com\/sk\/#website","url":"https:\/\/genekor.com\/sk\/","name":"Genekor","description":"\u039c\u03bf\u03c1\u03b9\u03b1\u03ba\u03ae \u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03ae","publisher":{"@id":"https:\/\/genekor.com\/sk\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/genekor.com\/sk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sk-SK"},{"@type":"Organization","@id":"https:\/\/genekor.com\/sk\/#organization","name":"Genekor","url":"https:\/\/genekor.com\/sk\/","logo":{"@type":"ImageObject","inLanguage":"sk-SK","@id":"https:\/\/genekor.com\/sk\/#\/schema\/logo\/image\/","url":"https:\/\/genekor.com\/wp-content\/uploads\/2021\/09\/logo-black.svg","contentUrl":"https:\/\/genekor.com\/wp-content\/uploads\/2021\/09\/logo-black.svg","width":1,"height":1,"caption":"Genekor"},"image":{"@id":"https:\/\/genekor.com\/sk\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/genekorbiotechnology\/","https:\/\/gr.linkedin.com\/company\/genekor-sa","https:\/\/www.youtube.com\/channel\/UCKC7sMFecVBY-OZAlRBHNzA"]},{"@type":"Person","@id":"https:\/\/genekor.com\/sk\/#\/schema\/person\/d6c43cd4b4be66582d408967392cbcbd","name":"Ioanna Potska","image":{"@type":"ImageObject","inLanguage":"sk-SK","@id":"https:\/\/secure.gravatar.com\/avatar\/51a22c866b60a1ab865aba05d68e60b9ed650b786b5ca87a11bb122b20cf2789?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/51a22c866b60a1ab865aba05d68e60b9ed650b786b5ca87a11bb122b20cf2789?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/51a22c866b60a1ab865aba05d68e60b9ed650b786b5ca87a11bb122b20cf2789?s=96&d=mm&r=g","caption":"Ioanna Potska"}}]}},"_links":{"self":[{"href":"https:\/\/genekor.com\/sk\/wp-json\/wp\/v2\/posts\/17809","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genekor.com\/sk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/genekor.com\/sk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/genekor.com\/sk\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/genekor.com\/sk\/wp-json\/wp\/v2\/comments?post=17809"}],"version-history":[{"count":0,"href":"https:\/\/genekor.com\/sk\/wp-json\/wp\/v2\/posts\/17809\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/genekor.com\/sk\/wp-json\/wp\/v2\/media\/17810"}],"wp:attachment":[{"href":"https:\/\/genekor.com\/sk\/wp-json\/wp\/v2\/media?parent=17809"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/genekor.com\/sk\/wp-json\/wp\/v2\/categories?post=17809"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/genekor.com\/sk\/wp-json\/wp\/v2\/tags?post=17809"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}